Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil.

Journal of child neurology - 1 Mar 2009

Pranzatelli Michael R, Tate Elizabeth D, Travelstead Anna L, Baumgardner Christine A, Gowda Narayana V, Halthore Sri N, Kerstan Peter, Kossak Brian D, Mitchell Wendy G, Taub Jeffrey W

Abstract excerpt

Opsoclonus-myoclonus syndrome is characterized by abnormal lymphocyte trafficking into brain. The authors hypothesized that mycophenolate mofetil, a lymphocyte proliferation inhibitor, might be therapeutic. The cerebrospinal fluid and blood immunophenotypes of 15 children with predominantly chron...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenocorticotropic Hormone
Share to Antibodies, Monoclonal, Murine-Derived

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunologic Factors

Share to Immunosuppressive Agents

Share to Lymphocyte Activation

Share to Mycophenolic Acid

Share to Pilot Projects

Share to Rituximab

Source

Identifiers

PMID: 19258290
DOI: 10.1177/0883073808324217

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19258290-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Insights on chronic-relapsing opsoclonus-myoclonus from a pilot study of mycophenolate mofetil.PMID 19258290Read ↗

Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort studySemantic proximity Read ↗

Ocrelizumab Impairs the Phenotype and Function of Memory CD8+ T Cells: A 1-Year Longitudinal Study in Patients With Multiple Sclerosis.Semantic proximity Read ↗

Successful treatment of rituximab-unresponsive elderly-onset neuromyelitis optica spectrum disorder and hypogammaglobulinemia with ofatumumab plus intravenous immunoglobulin therapy in a patient with mutant FCGR3A genotype: A case report.Semantic proximity Read ↗

Natalizumab effects on immune cell responses in multiple sclerosis.Semantic proximity Read ↗

Effect of inosine monophosphate dehydrogenase-1 gene polymorphisms on mycophenolate mofetil effectiveness in neuromyelitis optica spectrum disorder patients.Semantic proximity Read ↗

Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome.Semantic proximity Read ↗

Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosisSemantic proximity Read ↗

Single-cell analysis suggests coordinated immune-cell redistribution between blood and cerebrospinal fluid in early multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.